How Jumping Genes Drive Cancer Growth and Tumor Evolution

Transposable element activation in the human genome serves as a newly proposed hallmark of cancer, according to recent research published in Cancer Discovery by Katherine B. Chiappinelli and Kathleen H. Burns. While only one to two percent of the human genome codes for proteins, the majority consists of repetitive DNA and transposable elements, which remain active across species from plants to humans and become notably dysregulated in malignancies.

Understanding Transposable Elements in Cancer Biology

Transposable elements (TEs) are self-propagating pieces of DNA capable of moving throughout the genome, according to findings detailed by Katherine Chiappinelli, Associate Professor of Microbiology, Immunology and Tropical Medicine at The George Washington University. In healthy tissues, TEs contribute to gene regulation and cellular processes. However, in cancer cells, these elements are overexpressed and transcriptionally rewire cellular functions, causing genome instability.

Did you know? When the human genome was initially sequenced in 2003, researchers discovered that protein-coding genes make up a remarkably small fraction of our total DNA, leaving the vast majority comprised of repetitive sequences and transposable elements.

Viral Mimicry and Anti-Tumor Immune Responses

Beyond causing genomic instability, transposable elements activate innate and adaptive anti-tumor immune responses. Benjamin Greenbaum, Professor at Joan & Sanford I. Weill Medical College of Cornell University, along with Siyu Sun, explored this mechanism in an accompanying Cancer Discovery “In Focus” piece. Their work details how self RNAs, including TE sequences, trigger innate immune signaling through a process known as viral mimicry within cancer cells.

Therapeutic Vulnerabilities and Early Detection Strategies

Researchers propose viewing widespread transposable element expression and activation as a distinct therapeutic vulnerability in cancer. According to the published review, strategies aimed at targeting these vulnerabilities—as well as utilizing TEs for the early detection of malignancies—are now actively advancing toward clinical applications.

Frequently Asked Questions

What are transposable elements?

Transposable elements are self-propagating pieces of DNA that can move about the genome. They are found in organisms ranging from plants to humans and play a role in both normal gene regulation and disease states like cancer.

How do transposable elements affect cancer cells?

According to research by Katherine Chiappinelli and Kathleen Burns, TEs can transcriptionally rewire cancer cells, cause genome instability, and activate innate and adaptive anti-tumor immune responses through mechanisms like viral mimicry.

Kopchick Fellow Richa Nayak investigates the role of “jumping genes” in stem cells and human disease

Can transposable elements be used to detect cancer early?

Yes, strategies utilizing transposable element expression for the early detection of malignancies are currently advancing to clinical evaluation, according to recent literature in Cancer Discovery.

Stay Updated on Cancer Research

Subscribe to our newsletter for the latest updates on genomic research, oncology breakthroughs, and clinical trial developments.

Join Our Mailing List

Leave a Comment